Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

268.00 -5.54 (-2.03%)
Delayed Quote Updated: 9:58 AM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
News headline image
Baird Maintains Neutral Rating for Illumina: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings ↗
 
Via Benzinga
News headline image
Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues ↗
The company is fighting both regulators and its own shareholders to retain Grail. 
Via Investor's Business Daily
News headline image
This Is What Whales Are Betting On Illumina ↗
 
Via Benzinga
News headline image
A Preview Of Illumina's Earnings ↗
 
Via Benzinga
News headline image
Looking At Illumina's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
Profit from the Artificial Intelligence Boom with These 7 AI ETFs ↗
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
News headline image
Here's Why You Shouldn't Buy the Dip With Illumina Stock ↗
There aren't many factors driving its growth at the moment. 
Via The Motley Fool
News headline image
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market ↗
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at... 
Via Talk Markets
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
What Does Illumina's Debt Look Like? ↗
 
Via Benzinga
News headline image
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow ↗
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global... 
Via Benzinga
News headline image
Is There Any Hope for Illumina Stock? ↗
Being in trouble with regulators in two major markets sure won't help anything. 
Via The Motley Fool
News headline image
Illumina Unusual Options Activity ↗
 
Via Benzinga
News headline image
FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn ↗
 
Via Benzinga
News headline image
A Look Into Illumina's Debt ↗
 
Via Benzinga
News headline image
(ILMN) - Analyzing Illumina's Short Interest ↗
 
Via Benzinga
News headline image
The 3 Best Millionaire-Maker Stocks to Buy for April 2023 ↗
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 
Via InvestorPlace
News headline image
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle ↗
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell. 
Via Investor's Business Daily
News headline image
7 Stocks Gearing Up for a Major Breakout ↗
With the stock market gearing up for a major breakout, there are many potential breakout stocks at this point. 
Via InvestorPlace
News headline image
What's The Similiarity Between Disney And Illumina? Billionaire Activist Investor Wanted Retired CEO To Come Back ↗
After launching a proxy battle against Illumina Inc (NASDAQ: ILMN), activist investor Carl Icahn has clarified that he wants management change with former CEO Jay Flatley to come back and Grail... 
Via Benzinga
News headline image
Next Generation Sequencing Technology Market 2023 Innovation, Application, Future Trends, Outlook by Type, Application and Business Opportunities to 2030
Next Generation Sequencing Technology Market Growth and Outlook 2023-2030 SWOT Analysis by Key Players – Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life... 
Via SBWire
News headline image
This Favorable Sign Appears On Illumina's Chart ↗
 
Via Benzinga
News headline image
DNA Data Storage Alliance Announces Board Appointments
From DNA Data Storage Alliance
Via Business Wire
News headline image
Individual Stock Picks As The Fed Tightens Financial Conditions Further Despite Banking Stress ↗
We provide free access to the episode's chart pack, including all of the data discussed. 
Via Benzinga
News headline image
Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories ↗
Reuters 
Via Benzinga
News headline image
Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal ↗
 
Via Benzinga
News headline image
S&P 500 Losers: First Republic Crashes; Dow Giant Microsoft Slides ↗
First Republic is the new bank in focus. Microsoft fell below a buy point. 
Via Investor's Business Daily
News headline image
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time ↗
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.